References
- Genchi VA, D’Oria R, Palma G, Caccioppoli C, Cignarelli A, Natalicchio A, Laviola L, Giorgino F, Perrini S. Impaired leptin signalling in obesity: is leptin a new thermolipokine? Int J Mol Sci 22, 6445, 2021.
- Hanna C, Comstock F, Chatrath S, Posner A, Butsch J, Blum K, Gold MS, Georger S, Mastrandrea LD, Quattrin T, Thanos PK. Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative review. Front Public Health 13, 1516122, 2025.
- Sahin-Efe A, Polyzos SA, Dincer F, Zaichenko L, McGovern R, Schneider B, Mantzoros CS. Intracellular leptin signaling following effective weight loss. Metabolism 64, 888–895, 2015.
- Sarkar R. Patient selection in bariatric surgery. In obesity, bariatric and metabolic surgery: a comprehensive guide (pp. 121–140). Cham: Springer International Publishing 2023.
- Tabaeian SP, Mahmoudi T, Sabzikarian M, Rezamand G, Dabiri R, Nobakht H, Asadi A, Farahani H, Mansour- Ghanaei F, Zali MR. The Leu72Met (rs696217 G> T) polymorphism of the ghrelin gene might be a protective factor for nonalcoholic fatty liver disease. J Gastrointestin Liver Dis 30, 233–239, 2021.
- Thanos PK, Hanna C, Mihalkovic A, Hoffman AB, Posner AR, Busch J, Smith C, Badgaiyan RD, Blum K, Baron D, Mastrandrea LD, Quattrin T. The first exploratory personalized medicine approach to improve bariatric surgery outcomes utilizing psychosocial and genetic risk assessments: encouraging clinical research. J Pers Med 13, 1164, 2023.
- Vitolo E, Santini E, Seghieri M, Giannini L, Coppede F, Rossi C, Dardano A, Solini A. Heterozygosity for the rs696217 SNP in the preproghrelin gene predicts weight loss after bariatric surgery in severely obese individuals. Obes Surg 27, 961–967, 2017.